Marksans Pharma Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Marksans Pharma Limited with three other
companies in this sector in India:
Eris Lifesciences Ltd
sales of 7.25 billion Indian Rupees [US$112.59 million]
of which 100%
Bliss GVS Pharma Limited
(8.00 billion Indian Rupees [US$124.20 million]
Orchid Pharma Ltd
(8.07 billion Indian Rupees [US$125.39 million]
Marksans Pharma Limited reported sales of 7.67 billion Indian Rupees (US$119.14 million)
March of 2017.
decrease of 14.1%
versus 2016, when the company's sales were 8.93 billion Indian Rupees.